SPG logo

Springer Nature AG & Co. KGaA Stock Price

XTRA:SPG Community·€4.0b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

SPG Share Price Performance

€19.96
-2.24 (-10.09%)
€20.00
Fair Value
€19.96
-2.24 (-10.09%)
0.2% undervalued intrinsic discount
€20.00
Fair Value
Price €19.96
AnalystLowTarget €20.00
AnalystHighTarget €32.40
AnalystConsensusTarget €26.36

SPG Community Narratives

·
Fair Value €20 0.2% undervalued intrinsic discount

AI Spending And Open Access Pressures Will Threaten Margins Yet Underpin Long Term Resilience

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value €32.4 38.4% undervalued intrinsic discount

Open Access Leadership And AI Integration Will Support Powerful Long Term Tailwinds

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value €26.36 24.3% undervalued intrinsic discount

Open Access Expansion And New Nature Titles Will Support Long Term Earnings Potential

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
€32.4
38.4% undervalued intrinsic discount
Revenue
4.89% p.a.
Profit Margin
16.08%
Future PE
22.71x
Price in 2029
€41.65
€26.36
24.3% undervalued intrinsic discount
Revenue
3.82% p.a.
Profit Margin
14.31%
Future PE
19.93x
Price in 2029
€30.91

Trending Discussion

No trending discussion available.

Updated Narratives

SPG logo

SPG: ARC3 Licensing And AI Content Access Will Support Future Upside

Fair Value: €32.4 38.4% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
SPG logo

SPG: Street Research Range Will Shape Future Market Expectations

Fair Value: €20 0.2% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
SPG logo

SPG: Raised Price View And CFO Transition Will Support Future Upside

Fair Value: €26.36 24.3% undervalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Very undervalued with solid track record.

1 Risk
5 Rewards

Springer Nature AG & Co. KGaA Key Details

€2.0b

Revenue

€254.9m

Cost of Revenue

€1.7b

Gross Profit

€1.4b

Other Expenses

€327.6m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Nov 17, 2026
1.65
86.96%
16.75%
67.5%
View Full Analysis

About SPG

Founded
1842
Employees
9400
CEO
Franciscus Peeters
WebsiteView website
www.springernature.com

Springer Nature AG & Co. KGaA, together with its subsidiaries, engages in the publishing business in Germany, the United Kingdom, the United States, and internationally. The company operates through three segments: Research, Education, and Health. It offers journals across various academic disciplines under the Nature Portfolio and Springer brand names; books in print and digital formats across various scientific disciplines, including monographs, textbooks, conference proceedings, handbook series, reference works, and briefs under the Springer and Palgrave Macmillan brand names; and support services to researchers, institutions, and industry professionals with AI-powered tools and services, such as AdisInsight, Springer Nature Experiments, protocols.io, and SpringerMaterials, as well as professional development and career services under the Nature Masterclasses, Nature Careers, and Nature Conferences brand names. The company also provides English language teaching content and national curricula learning resources under the Macmillan Education brand name. In addition, it offers specialist information and services to healthcare professionals under the Springer Medizin brand name; publications, learning solutions, and professional services to healthcare practitioners and students under the BSL brand name; content and services related to drug treatments, medical devices, and diagnostics under the Springer Health+ brand name; and Cureus Journal of Medical Science, a peer-reviewed OA medical journal. The company was founded in 1842 and is based in Berlin, Germany. Springer Nature AG & Co. KGaA operates as a subsidiary of GvH Vermögensverwaltungsgesellschaft Xxxiii mbH.

Recent SPG News & Updates

Analysis Article Aug 07

Here's What Analysts Are Forecasting For Springer Nature AG & Co. KGaA (ETR:SPG) After Its Interim Results

It's been a good week for Springer Nature AG & Co. KGaA ( ETR:SPG ) shareholders, because the company has just released...
Narrative Update Aug 06

SPG: ARC3 Licensing And AI Content Access Will Support Future Upside

Analysts have nudged their fair value estimate for Springer Nature KGaA from €31.00 to €32.40. This aligns with a higher Street price target of €26.90 and updated assumptions on discount rate, revenue growth, profit margins and future P/E multiples.

Recent updates

No updates